A recent development in Botox-type injectables is TrenibotE (trenibotulinumtoxinE), a novel neuromodulator from AbbVie—the pharmaceutical company behind Allergan Aesthetics and Botox® Cosmetic. AbbVie is currently seeking FDA approval for TrenibotE to treat moderate to severe glabellar lines, commonly known as frown lines or “11s” between the eyebrows. What makes TrenibotE noteworthy is its unique clinical […]
Evolus expanded beyond its neuromodulator Jeuveau® (“Newtox”) with the launch of its first hyaluronic acid-based dermal fillers: Evolysse™ Form and Evolysse™ Smooth earlier this year. Both products are FDA-approved for the treatment of moderate to severe nasolabial folds and smile lines and join a competitive category that includes established products like Juvéderm®, Restylane®, and RHA®. […]
Medications such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™) belong to a class called glucagon-like peptide-1 (GLP-1) receptor agonists. Originally FDA-approved for type 2 diabetes, several now carry indications for weight management and cardiovascular risk reduction. Explosive demand, and the resulting shortage of the drugs, led the FDA to allow compounding pharmacies to make […]
The American Board of Cosmetic Surgery will be led by Arkansas cosmetic surgeon Dr. Jeffrey Swetnam Munster, IN, March 20, 2024 /PRNewswire/—The American Board of Cosmetic Surgery (ABCS) announced that Jeffrey A. Swetnam, MD, FACS, FAACS will become the organization’s President beginning in 2024. Dr. Swetnam takes over from Immediate Past President Mohammad Banki, MD, […]
Galderma recently announced the newest dermal filler in the Restylane® family of fillers, Eyelight™, has received FDA approval to improve the appearance of depressed, sunken, or hollow areas under the eyes (infraorbital hollowing). Here’s what you need to know about Restylane Eyelight. What is Restylane Eyelight? Restylane Eyelight is the newest injectable hyaluronic acid (HA) […]
Diplomates of the American Board of Cosmetic Surgery support new legislative measures, including required ultrasound guidance, to protect patients seeking Brazilian butt lift from dangerous complications Chicago, IL, August 31, 2023 /PRNewswire/ — Diplomates of the American Board of Cosmetic Surgery (ABCS) praised a new Florida law mandating ultrasound guidance and other safety measures for all […]
Allergan Aesthetics announced in May that the FDA approved a new dermal filler in the Juvéderm® family of fillers: Skinvive™. While every new injectable promises to achieve somewhat different results, Skinvive is noteworthy because it is injected with a novel microdroplet approach and is indicated to improve skin smoothness, rather than to correct wrinkles or […]
IDEAL IMPLANT ended operations on May 30, 2023, citing financial reasons. The company’s proprietary “structured saline” breast implants, used in breast augmentation surgery, will no longer be manufactured, and warranties on these implants will no longer be honored by the manufacturer. Below are some of the implications of this change. What is an IDEAL implant? […]
Sculptra® Aesthetic, the first poly-L-lactic acid (PLLA) dermal filler used to restore natural-looking facial volume, has recently been granted FDA approval to treat fine lines and wrinkles throughout the cheek area. What is Sculptra? Sculptra is a biocompatible injectable made up of tiny particles of a synthetic polymer called poly-L-lactic acid (PLLA), carboxymethylcellulose (USP), non-pyrogenic […]
Juvéderm Volbella XC, one of the most widely-used dermal fillers, has recently been approved by the FDA for injection into the under-eye area of the face. While hyaluronic acid-based fillers have been used “off-label” for years to reduce the appearance of under-eye hollows, Volbella is the first filler officially approved for this application. Read on […]